Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Walsh, Tanya ^a   Liu, Joseph L Y ^b   Brocklehurst, Paul ^a   Glenny, Anne Marie ^a   Lingen, Mark ^c   Kerr, Alexander R ^d   Ogden, Graham ^b   Warnakulasuriya, Saman ^e   Scully, Crispian ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF CHICAGO   (United States)

^d NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOLONIUM CHLORIDE;

ADULT; CANCER GROWTH; CANCER SCREENING; CLINICAL ASSESSMENT; CLINICAL OUTCOME; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; EARLY CANCER DIAGNOSIS; FOLLOW UP; HUMAN; MOUTH CANCER; MOUTH EXAMINATION; MOUTH HYGIENE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SELF EXAMINATION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; EARLY DIAGNOSIS; HEALTH STATUS; LIP TUMOR; META ANALYSIS; METHODOLOGY; MOUTH TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD;

ADULT; EARLY DETECTION OF CANCER; HEALTH STATUS; HUMANS; LIP NEOPLASMS; MOUTH NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 84900971913     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010173.pub2     Document Type: Review

References (104)

1. Chang IH, Jiang RS, Wong YK, Wu SH, Chen FJ, Liu SA. Visual screening of oral cavity cancer in a male population: experience from a medical center. Journal of the Chinese Medical Association 2011;74(12):561-6.
2. Downer MC, Evans AW, Hughes Hallett CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dentistry and Oral Epidemiology 1995;23(2):84-8.
3. Elango KJ, Anandkrishnan N, Suresh A, Iyer SK, Ramaiyer SK, Kuriakose MA. Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population. Oral Oncology 2011;47(7):620-4.
4. Ikeda N, Downer MC, Ishii T, Fukano H, Nagao T, Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dental Health 1995;12(3):133-7.
5. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dental Health 1995;12:3-7.
6. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dental Health 1995;12:3-7.
7. Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. British Journal of Cancer 1997;76(3):390-4.
8. Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahé C, et al. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncology 2003;39(6):580-8.
9. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 2000;88(3):664-73.
10. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, et al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncology 2013;49(4):314-21.
11. Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detection and Prevention 1986;9(3-4):219-25.
12. Scott SE, Rizvi K, Grunfeld EA, McGurk M. Pilot study to estimate the accuracy of mouth self-examination in an at-risk group. Head and Neck 2010;32(10):1393-401.
13. Su WW, Yen AM, Chiu SY, Chen TH. A community-based RCT for oral cancer screening with toluidine blue. Journal of Dental Research 2010;89(9):933-7.
14. Sweeny L, Dean NR, Magnuson JS, Carroll WR, Clemons L, Rosenthal EL. Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Journal of Otolaryntology - Head and Neck Surgery 2011;145(6):956-60.
15. Warnakulasuriya KA, Ekanayake AN, Sivayoham S, Stjernswärd J, Pindborg JJ, Sobin IH, et al. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bulletin of the World Health Organization 1984;62(2):243-50.
16. Warnakulasuriya S, Pindborg JJ. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dental Health 1990;7(1):73-9.
17. Warnakulasuriya KA, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detection and Prevention 1991;15(5):331-4.
18. Bhalang KA, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2008;106(3):371-6.
19. Bowles DA Jr, Levin ES, Hasler JF. A comparison of two cytologic methods for mass screening against oral cancer. Journal of Oral Surgery 1973;31(11):830-6.
20. Chen YW, Lin JS, Fong JH, Wang IK, Chou SJ, Wu CH, et al. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. British Journal of Oral and Maxillofacial Surgery 2007;45(7):590-1.
21. Csépe P, Bánóczy J, Dombi C, Forrai J, Gyenes M, Döbrossy L. Model program for screening oral cancers in the Roma population. Magyar Onkologia 2007;51(2):95-101.
22. Fernández Garrote L, Sankaranarayanan R, Lence Anta JJ, Rodriguez Salvá A, Maxwell Parkin D. An evaluation of the oral cancer control program in Cuba. Epidemiology 1995;6(4):428-31.
23. Hapner ER, Wise JC. Results of a large-scale head and neck cancer screening of an at-risk population. Journal of Voice 2011;25(4):480-3.
24. Huber MA, Bsoul SA, Terzhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence International 2004;35(5):378-84.
25. HuffK, Stark PC, Solomon LW. Sensitivity of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice. General Dentistry 2009;57(1):34-8.
26. Leocata P, D'Alessandro A, D'Amario M, Barone A, Giannoni M. A screening program for the early detection and prevention of oral cancer. Journal of Plastic Dermatology 2007;3(1):71-5.
27. Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. British Dental Journal 2003;194(9):497-502.
28. Nagao T, Ikeda N, Fukano H, Miyazeki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncology 2000;36:340-6.
29. Nagao T, Warnakulasuriya S. Annual screening for oral cancer detection. Cancer Detection and Prevention 2003;27:333-7.
30. Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. Journal of Medical Screening 2000;7(4):203-8.
31. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. Journal of Oral and Maxillofacial Surgery 2007;65(3):424-6.
32. Poh CF, Hislop G, Currie B, Lee R, Sikorski S, Zed C, et al. Oral cancer screening in a high-risk underserved community--Vancouver Downtown Eastside. Journal of Health Care for the Poor and Underserved 2007;18(4):767-78.
33. Srivastava YC, Mathur MN. Toluidine blue staining test for early detection of oral cancer: an adjunct to biopsy. Dental Digest 1971;77(7):400-3.
34. Vahidy NA, Zaidi SH, Jafarey NA. Toludine blue test for detection of carcinoma of the oral cavity: an evaluation. Journal of Surgical Oncology 1972;4(5):434-8.
35. Warnakulasuriya S, Kashyap R, Dasanayake AP. Is workplace screening for potentially malignant oral disorders feasible in India?. Journal of Oral Pathology and Medicine 2010;39(9):672-6.
36. Barrellier P, Rame JP, Chasle J, Souquières Y. Detection of buccal cavity cancers with toluidine blue (author's transl). Revue de Stomatologie et de Chirurgie Maxillo-Faciale 1980;81(6):364-7.
37. Barrellier P, Rame JP, Chasle J, Souquières Y, Lecacheux B. Detection of cancer of the oral cavity using toluidine blue. Actualités Odonto-Stomatologiques 1982;36(137):87-92.
38. Marzouki HZ, Tuong Vi Vu T, Ywakim R, Chauvin P, Hanley J, Kost KM. Use of fluorescent light in detecting malignant and premalignant lesions in the oral cavity: a prospective, single-blind study. Journal of Otolaryngology - Head and Neck Surgery 2012;41(3):164-8.
39. Vacher C, Legens M, RueffB, Lezy JP. Screening of cancerous and precancerous lesions of the oral mucosa in an at-risk population. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 1999;100:180-3.
40. Kulak J, Franzmann E. The use of autofluorescence in detection of oral lesions. The Laryngoscope 2010;120(S3):S40.
41. American Cancer Society. Update January 1992: the American Cancer Society guidelines for the cancer-related checkup. CA: a Cancer Journal for Clinicians 1992;42(1):44-5.
42. Bessell A, Glenny A-M, Furness S, Clarkson JE, Oliver R, Conway DI, et al. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD006205.pub3]
43. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncology 2011;47(1):51-5.
44. Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening: what have we learnt and what is there still to achieve?. Future Oncology 2010;6(2):299-304.
45. Brocklehurst PR, Ashley JR, Tickle M. Patient assessment in general dental practice - risk assessment or clinical monitoring?. British Dental Journal 2011;210(8):351-4.
46. Brocklehurst P, Kujan O, O'Malley LA, Ogden G, Shepherd S, Glenny AM. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD004150.pub4]
47. Buchen L. Cancer: Missing the mark. Why is it so hard to find a test to predict cancer?. Nature 2011;471(7339):428-32.
48. Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/oral/uk-oral-cancer-statistics.
49. Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M, Macpherson LM. Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. International Journal of Cancer 2008;122(12):2811-9.
50. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncology 2004;40(3):264-73.
51. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. In: Kogevinas M, Pearce N, Susser M, Boffetta P editor(s). Social Inequalities and Cancer. Lyon: IARC Scientific Publications No 138. International Agency for Research in Cancer, 1997.
52. Fedele S. Diagnostic aids in the screening of oral cancer. Head & Neck Oncology 2009;1:5.
53. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010;127(12):2893-917.
54. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A. Prospective investigation of the cigarette smoking-head and neck association by sex. Cancer 2007;110(7):1593-601.
55. Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD006386.pub3]
56. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005;293(10):1223-38.
57. Glenny AM, Furness S, Worthington HV, Conway DI, Oliver R, Clarkson JE, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD006387.pub2]
58. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncology 2006;42(5):461-74.
59. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable?. Journal of Oral Pathology and Medicine 2007;36(5):262-6.
60. Holmstrup P. Can we prevent malignancy by treating premalignant lesions?. Oral Oncology 2009;45:549-50.
61. Jaber MA, Porter SR, Speight P, Eveson JW, Scully C. Oral epithelial dysplasia: clinical characteristics of western European residents. Oral Oncology 2003;39(6):589-96.
62. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 2008;58(2):71-96.
63. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncology 1997;33(5):302-12.
64. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-74.
65. Lee JM, Garon E, Wong DT. Salivary diagnostics. Orthodontics and Craniofacial Research 2009;12(3):206-11.
66. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM, Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Annals of Internal Medicine 2008;149(12):889-97.
67. Seoane Leston J, Diz Dios P. Diagnostic clinical aids in oral cancer. Oral Oncology 2010;46(6):418-22.
68. Li Y, ElashoffD, Oh M, Sinha U, St John MA, Zhou X, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. Journal of Clinical Oncology 2006;24(11):1754-60.
69. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncology 2008;44(1):10-22.
70. Liu JL, Wyatt JC, Deeks JJ, Clamp S, Keen J, Verde P, et al. Systematic reviews of clinical decision tools for acute abdominal pain. Health Technology Assessment 2006;10(47):1-167.
71. Liu JLY, Walsh T, Kerr AR, Lingen M, Brocklehurst P, Ogden G, et al. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD010276]
72. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD001829.pub3]
73. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, Brasure J, et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. European Journal of Cancer. Part B, Oral Oncology 1995;31B(3):181-7.
74. Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. American Journal of Surgery 1988;156(4):273-5.
75. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA: A Cancer Journal for Clinicians 1995;45(6):328-51.
76. McGurk M, Scott SE. The reality of identifying early oral cancer in the general dental practice. British Dental Journal 2010;208(8):347-51.
77. Moles DR, Downer MC, Speight PM. Meta-analysis of measures of performance reported in oral cancer and precancer screening studies. British Dental Journal 2002;192(6):340-4.
78. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. Journal of Oral Pathology and Medicine 2008;37(1):1-10.
79. Netuveli G, Sheiham A, Watt RG. Does the 'inverse screening law' apply to oral cancer screening and regular dental check-ups?. Journal of Medical Screening 2006;13(1):47-50.
80. Ogden GR. Alcohol and oral cancer. Alcohol 2005;35(3):169-73.
81. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncology 2001;2(9):533-43.
82. Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. Journal of American Dental Association 2008;139(7):896-905.
83. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncology 2003;39(8):770-80.
84. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Critical Reviews in Oral Biology and Medicine 2003;14(1):47-62.
85. Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Journal of the American Dental Association 2010;141(5):509-20.
86. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
87. Rogers SN, Brown JS, Woolgara JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncology 2009;45(3):201-11.
88. National Institute of Dental and Craniofacial Research. Bringing the promise of molecular medicine to oral cancer screening. http://www.nidcr.nih.gov/Research/ResearchResults/InterviewsOHR/TIS032006.htm (accessed 18th April 2011).
89. Rusthoven KE, Raben D, Song JI, Kane M, Altoos TA, Chen C. Survival and patterns of relapse in patients with oral tongue cancer. Journal of Oral and Maxillofacial Surgery 2010;68(3):584-9.
90. Sankaranarayanan R. Health care auxiliaries in the detection and prevention of oral cancer. Oral Oncology 1997;33(3):149-54.
91. Scully C, Shotts R. ABC of oral health. Mouth ulcers and other causes of orofacial soreness and pain. BMJ 2000;321(7254):162-5.
92. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncology 2009;45(4-5):301-8.
93. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53(3):563-8.
94. Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technology Assessment 2006;10(14):1-144.
95. Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Matthew B, et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bulletin of the World Health Organization 2009;87(3):200-6.
96. US Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/(accessed 8th April 2011).
97. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa: terminology, classification and present concepts of management. Oral Oncology 2009;45(4-5):317-23.
98. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of Oral Pathology and Medicine 2007;36(10):575-80.
99. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 2009;45(4-5):309-16.
100. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Annals of Internal Medicine 2004;140(3):189-202.
101. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36.
102. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Boletín de la Oficina Sanitaria Panamericana 1968;65(4):281-393.
103. Wyatt JC, Altman DG. Commentary: Prognostic models: clinically useful or quickly forgotten?. BMJ 1995;311:1539.
104. Yusof ZY, Netuveli G, Ramli AS, Sheiham A. Is opportunistic oral cancer screening by dentists feasible? An analysis of the patterns of dental attendance of a nationally representative sample over 10 years. Oral Health and Preventive Dentistry 2006;4(3):165-71.